Citation:Toes REM, Huizinga TWJ (2009) Autoimmune Responses in the Rheumatoid Synovium. PLoS Med 6(1): e1000009. doi:10.1371/journal.pmed.1000009
Published: January 13, 2009
Copyright: © 2009 Toes and Huizinga. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors received no specific funding for this article.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: ACPA, anti-citrullinated protein/peptide antibody;AID, activation-induced cytidine deaminase;FDC, follicular dendritic cell;RA, rheumatoid arthritis
Provenance: Commissioned; not externally peer reviewed
Rheumatoid arthritis (RA) is a chronic inflammatory disorder affecting joints, often with severe and disabling consequences. Although cells and intracellular signals characterizing inflamed tissue in RA are not qualitatively different from those found in other conditions, in about one third of patients with RA ectopic lymphoid structures can be found in affected tissue . These structures, which form in response to sustained local inflammation, reflect the anatomical organization through which lymph nodes regulate the initiation and maturation of productive adaptive immune responses. Ectopic lymphoid structures therefore appear potentially capable of similarly mediating the encounter and interaction of immune cells with antigens.
Ectopic Lymphoid Structures and Autoantibodies
It has long been speculated that ectopic lymphoid structures are not only generated in response to inflammation, but might also contribute to inflammation itself by supporting the formation and perpetuation of pathogenic immune responses .
Anti-citrullinated protein/peptide antibodies (ACPAs) are antibodies that recognize post-translationally modified proteins in which arginine residues have been modified into citrulline [3,4]. These antibodies are highly specific for RA, directed against antigens that are also expressed in the inflamed joint and can sometimes be detected up to ten years before disease development [5,6]. Because of these features, combined with the observations that their presence predicts clinical outcome in RA, and that their infusion exacerbates arthritis in animals, it is thought that ACPAs contribute to RA pathogenesis [7–9]. It has also been shown that synovial tissue can harbor cells that produce ACPAs [10,11].
Linked Research Article
This Perspective discusses the following new study published in PLoS Medicine:
Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, et al. (2009) Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 6(1): e1. doi:10.1371/journal.pmed.0060001
Costantino Pitzalis and colleagues show that lymphoid structures in synovial tissue of patients with rheumatoid arthritis support production of anti-citrullinated peptide antibodies, which continues following transplantation into SCID mice.
In a new study published in PLoS Medicine , Costantino Pitzalis and co-workers therefore investigated whether ectopic lymphoid structures present in the inflamed synovium of patients with RA actively contribute to ongoing B cell responses and whether they are involved in the production of ACPAs .
The authors analyzed the presence of follicular dendritic cells (FDCs) as a measure of the presence and extent of ectopic lymphoid structures. In lymph nodes, FDCs make intimate contact with B cells and play a key role in selecting antigen-binding B cells during the development of antibody responses. The authors observed that the presence of FDCs was strictly correlated with the expression of activation-induced cytidine deaminase (AID), an enzyme involved in antibody-isotype switching and affinity maturation, two processes crucial to the development of B cell antibody responses. Likewise, AID expression was correlated with markers implicated in the formation of lymphoid structures. Interestingly, cellular aggregates containing FDCs and expressing AID were found to be surrounded with cells recognizing citrullinated proteins but not control proteins, indicating the presence of ACPA-producing B cells. Together, these results indicate that the cellular aggregates associated with FDCs are functional and suggest that they contribute to the production of ACPAs.
Next the authors transplanted pieces of inflamed synovium from a series of joint biopsies in patients with RA into immunodeficient mice and followed the maintenance of germinal center–like structures in vivo as well as the survival and function of autoantibody-producing B cells. These experiments further confirmed the presence of active and self-sustained lymphoneogenesis within the inflamed synovium of patients with RA. In mice as in ex vivo human specimens, these ectopic lymphoid structures were associated with ongoing B cell responses as measured by the expression of AID and the presence of DNA recombination products that are only produced by B cells during antibody-isotype switching. ACPAs in serum were also detected, but only in those mice that were transplanted with synovial tissue that contained AID-positive cells and thus allowed for an ongoing B cell response possibly involving ACPA-isotype switching and affinity maturation.
Strengths, Limitations, and Next Steps
The data presented by Pitzalis and co-workers show that B cells that are associated with ectopic lymphoid structures express the molecular machinery required for antibody-isotype switching and affinity maturation. Likewise, they indicate that these ectopic lymphoid structures could act as a functional tertiary lymphoid organ capable of producing isotype-switched autoantibodies. These observations are in line with the evidence suggesting that new B cells are continuously recruited into the ACPA response and indicate that the inflamed synovium is facilitating and contributing to a perpetual reactivation of the RA-specific ACPA response during the course of ACPA-positive arthritis .
Nonetheless, the data presented do not provide definitive proof that ectopic lymphoid structures in RA synovium support the production of ACPAs. The authors demonstrate a clear and convincing association between the presence of ectopic structures, AID-positive cells in synovial tissue, and production of ACPAs by synovial tissue, indicating that the ectopic structures and/or AID-positive cells produce or support the production of ACPAs. Nonetheless, it is not shown that disrupting the ectopic structures inhibits the formation of ACPAs. Moreover, a recent study has indicated that synovial lymphoid neogenesis is not correlated with the level of autoantibodies in RA patients, suggesting that ectopic lymphoid structures contribute little to the ACPA levels measured in serum or synovial fluid . Therefore, it is important to delineate the pathogenic impact of ectopic lymphoid structures and the contribution of lymphoid neogenesis to the overall ACPA response in future studies. This could be achieved by disruption of the ectopic lymphoid structures and/or inhibition of lymphoneogenesis by targeting molecules regulating this process using the elegant mouse model developed by the authors, which closely recapitulates several of the hallmarks taking place in humans.
The new data presented by Pitzalis and colleagues indicate that lymphoneogenesis in the inflamed synovial tissue of patients with RA is fostering potentially pathogenic immune responses by assisting the local production of ACPAs. This could promote local inflammation, leading to a vicious circle in which more lymphogenic factors are produced, allowing a further perpetuation of the autoimmune responses that drive the ongoing disease process . Overall, the data presented increase our understanding of the relevance and functional consequences of the microanatomical immunological units present in a substantial number of patients with RA and provide a rationale to target these units as a new treatment modality for RA.
- 1. Takemura S,Braun A,Crowson C,Kurtin PJ,Cofield RH,et al. (2001) Lymphoid neogenesis in rheumatoid synovitis. J Immunol 167: 1072–1080.
- 2. Aloisi F,Pujol-Borrell R (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6: 205–217.
- 3. Girbal-Neuhauser E,Durieux JJ,Arnaud M,Dalbon P,Sebbag M,et al. (1999) The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 162: 585–594.
- 4. Schellekens GA,de Jong BA,van den Hoogen FH,van de Putte LB,van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101: 273–281.
- 5. Nielen MM,van SD,Reesink HW,van de Stadt RJ,van der Horst-Bruinsma IE,et al. (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum 50: 380–386.
- 6. Zendman AJ,van Venrooij WJ,Pruijn GJ (2006) Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology (Oxford) 45: 20–25.
- 7. Kuhn KA,Kulik L,Tomooka B,Braschler KJ,Arend WP,et al. (2006) Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 116: 961–973.
- 8. van Gaalen FA,Linn-Rasker SP,van Venrooij WJ,de Jong BA,Breedveld FC,et al. (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study. Arthritis Rheum 50: 709–715.
- 9. van Gaalen F,Ioan-Facsinay A,Huizinga TW,Toes RE (2005) The devil in the details: The emerging role of anticitrulline autoimmunity in rheumatoid arthritis. J Immunol 175: 5575–5580.
- 10. Masson-Bessiere C,Sebbag M,Durieux JJ,Nogueira L,Vincent C,et al. (2000) In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 119: 544–552.
- 11. Iwaki-Egawa S,Matsuno H,Ogawa Y,Watanabe Y (2005) Production of anti-CCP antibodies and matrix metalloproteinase-3 by human rheumatoid arthritis synovial tissues using SCID mice. Ann Rheum Dis 64: 1094–1095.
- 12. Humby F,Bombardieri M,Manzo A,Kelly S,Blades MC,et al. (2009) Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 6: e1. doi:10.1371/journal.pmed.0060001.
- 13. Verpoort KN,Jol-van der Zijde CM,Papendrecht-van der Voort EA,Ioan-Facsinay A,Drijfhout JW,et al. (2006) Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum 54: 3799–3808.
- 14. Cantaert T,Kolln J,Timmer T,van der Pouw Kraan TC,Vandooren B,et al. (2008) B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis. J Immunol 181: 785–794.